IAS Conference on HIV Science

Healio brings you the highlights from the IAS Conference on HIV Science. Refer back to this page often for the latest news from IAS, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.
Meeting News

Mytesi improves chronic diarrhea in HIV patients long-term

August 1, 2017
Mytesi, the only anti-diarrheal approved by the FDA for treating noninfectious diarrhea in adults with HIV/AIDS, generated significant long-term…
Meeting News

HIV drugs show promise in phase 3 trials

July 31, 2017
Several investigational HIV drugs or drug regimens showed promise in recent phase 3 trials, according to findings presented at the International AIDS…
Meeting News

Janssen’s HIV vaccine shows promise in clinical trial

July 28, 2017
Janssen Pharmaceuticals’ lead investigational HIV vaccine regimen that targets a wide variety of HIV-1 subtypes was well-tolerated and elicited…
Meeting News

Swaziland halves rate of new HIV infections

July 28, 2017
Swaziland, which has the highest HIV prevalence and incidence of any country in the world, reduced its rate of new infections by nearly half over the…
Meeting News

Dapivirine vaginal ring safe, acceptable for HIV prevention in teens

July 25, 2017
A monthly vaginal ring containing the antiretroviral dapivirine has demonstrated efficacy in girls younger than 18 years, according to phase 2a study…
Meeting News

Fearing drug interactions, transgender women may skip HIV, hormone therapy

July 25, 2017
A high proportion of transgender women with HIV who were surveyed said they did not adhere to either ART, feminizing hormone therapy or both for fear…
Meeting NewsPerspective

Child with HIV suppresses virus for more than 8 years without ART

July 24, 2017
A South African child who was diagnosed with HIV as an infant has suppressed the virus for the past 8 1/2 years without treatment, researchers said…
Meeting News

LATTE-2: Two-drug injectable ART regimen as effective as three-drug oral regimen

July 24, 2017
A two-drug injectable ART regimen received monthly or bimonthly is as effective in maintaining HIV suppression as a three-drug oral regimen through…
Advertisement
Advertisement